Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension

MLA

Hans-Juergen Woerle, et al. “Impact of Empagliflozin on Blood Pressure in Dipper and Non-Dipper Patients with Type 2 Diabetes Mellitus and Hypertension.” Diabetes, Obesity and Metabolism, vol. 19, July 2017, pp. 1620–24. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a7212e7a57946f3fa3165262353bff0a&authtype=sso&custid=ns315887.

APA

Hans-Juergen Woerle, Robert J. Chilton, Odd Erik Johansen, Uwe Hehnke, & Ilkka Tikkanen. (2017). Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension. Diabetes, Obesity and Metabolism, 19, 1620–1624.

Chicago

Hans-Juergen Woerle, Robert J. Chilton, Odd Erik Johansen, Uwe Hehnke, and Ilkka Tikkanen. 2017. “Impact of Empagliflozin on Blood Pressure in Dipper and Non-Dipper Patients with Type 2 Diabetes Mellitus and Hypertension.” Diabetes, Obesity and Metabolism 19 (July): 1620–24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a7212e7a57946f3fa3165262353bff0a&authtype=sso&custid=ns315887.